We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-15.72%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$4.46B
AUM Growth
-$6B
Cap. Flow
-$4.51B
Cap. Flow %
-101.07%
Top 10 Hldgs %
21.21%
Holding
7,134
New
733
Increased
2,939
Reduced
2,324
Closed
739

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$411M
2
MSFT icon
Microsoft
MSFT
+$372M
3
AMZN icon
Amazon
AMZN
+$192M
4
TSLA icon
Tesla
TSLA
+$121M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$111M

Sector Composition

Rank Sector Weight
1 Technology 22.55%
2 Healthcare 10.82%
3 Consumer Discretionary 9.19%
4 Financials 8.34%
5 Communication Services 7.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BBLN
4251
DELISTED
Babylon Holdings Limited
BBLN
$13K ﹤0.01%
530
+494
+1,372% +$21.6K
INDT
4252
DELISTED
INDUS Realty Trust, Inc. (MD) Common Stock
INDT
$13K ﹤0.01%
223
-511
-70% -$34K
ACOR
4253
DELISTED
Acorda Therapeutics
ACOR
$13K ﹤0.01%
1,362
+1,333
+4,597% +$23.7K
SGFY
4254
DELISTED
Signify Health, Inc.
SGFY
$13K ﹤0.01%
931
-6,296
-87% -$88.6K
SIOX
4255
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$13K ﹤0.01%
35,014
+26,752
+324% +$11.1K
RUBY
4256
DELISTED
Rubius Therapeutics, Inc
RUBY
$13K ﹤0.01%
15,002
+14,255
+1,908% +$23.9K
HCIC
4257
DELISTED
Hennessy Capital Investment Corp. V Class A Common Stock
HCIC
$13K ﹤0.01%
1,310
-657
-33% -$6.45K
AMPI.U
4258
DELISTED
Advanced Merger Partners Inc Units
AMPI.U
$13K ﹤0.01%
1,314
BSKY
4259
DELISTED
Big Sky Growth Partners, Inc. Class A Common Stock
BSKY
$13K ﹤0.01%
1,322
-82
-6% -$799
DWPP
4260
DELISTED
First Trust Dorsey Wright People's Portfolio ETF
DWPP
$13K ﹤0.01%
463
-4
-0.9% -$120
ETAC
4261
DELISTED
E.Merge Technology Acquisition Corp. Class A Common Stock
ETAC
$13K ﹤0.01%
1,327
+496
+60% +$4.93K
EMBK
4262
DELISTED
Embark Technology, Inc. Common Stock
EMBK
$13K ﹤0.01%
+1,304
New +$76.1K
BLPH
4263
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$13K ﹤0.01%
10,625
+9,049
+574% +$12.1K
AILE
4264
DELISTED
iLearningEngines, Inc. Common Stock
AILE
$13K ﹤0.01%
1,334
-2
-0.1% -$20
AFARU
4265
DELISTED
Aura FAT Projects Acquisition Corp Unit
AFARU
$13K ﹤0.01%
+1,289
New +$12.8K
AAXJ icon
4266
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.86B
$12K ﹤0.01%
176
-128
-42% -$9.03K
ALSN icon
4267
Allison Transmission
ALSN
$10.3B
$12K ﹤0.01%
312
-11,536
-97% -$441K
BNBX
4268
DELISTED
BNB PLUS CORP
BNBX
$12K ﹤0.01%
+1
New +$21.2K
BW icon
4269
Babcock & Wilcox
BW
$1.52B
$12K ﹤0.01%
1,932
-5,751
-75% -$40.3K
BWMN icon
4270
Bowman Consulting
BWMN
$732M
$12K ﹤0.01%
951
-1,676
-64% -$25.8K
BNC
4271
CEA Industries
BNC
$108M
$12K ﹤0.01%
+810
New +$14.7K
CNA icon
4272
CNA Financial
CNA
$13.8B
$12K ﹤0.01%
261
-527
-67% -$24.2K
CTRN icon
4273
Citi Trends
CTRN
$612M
$12K ﹤0.01%
506
-22,602
-98% -$637K
DCTH icon
4274
Delcath Systems
DCTH
$588M
$12K ﹤0.01%
3,038
+1,275
+72% +$6.52K
DTIL icon
4275
Precision BioSciences
DTIL
$201M
$12K ﹤0.01%
255
+147
+136% +$8.63K

Similar funds

Tower Research Capital (TRC)'s Q2 2022 Portfolio in Review

As of Q2 2022, Tower Research Capital (TRC) held 7,134 positions worth $4.46B, down 57% from $10.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.51B in Q2 2022, closing 739 positions and reducing 2,324 holdings. Its most notable exit was iShares MSCI USA Value Factor ETF, an estimated $13.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 Value ETF worth $23.4M.

  • Tower Research Capital (TRC)'s largest Q2 2022 buy was iShares Russell 1000 Value ETF: 161,690 shares worth $23.4M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q2 2022, an estimated $41.1M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2022 reduction was Apple, cutting an estimated $411M.
  • Tower Research Capital (TRC) fully exited iShares MSCI USA Value Factor ETF in Q2 2022, selling an estimated $13.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 21% of its $4.46B portfolio in Q2 2022.
  • Tower Research Capital (TRC) opened 733 new positions and closed 739 in Q2 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 57% quarter-over-quarter to $4.46B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2022, filed 15 Aug 2022.